Urodynamix Technologies Ltd. has an exclusive worldwide license to intellectual property held by The University of British Columbia (UBC) related to the use of NIRS in the diagnosis of bladder conditions. Urodynamix also has a number of additional patents pending for the use of NIRS in a variety of medical applications.

Intellectual Property for Urology Applications

The first US provisional patent application entitled “Spectrophotometric Technique for Patient Monitoring of Bladder Oxygenation” was filed October 15, 2003. Additional research, human trials, and further refinement of the technique continued, and on July 7, 2004 a second provisional patent application entitled “Methods and Apparatus for Urodynamic Analysis” was filed in Canada and in the United States. These provisional applications were subsequently combined, along with additional human clinical data, in a PCT application filed October 14, 2004.

Other Applications

Urodynamix has filed provisional patent applications relating to NIRS technologies including:

-- Methods and systems for detecting Compartment Syndrome
-- Methods and systems for diagnosing Erectile Dysfunction
-- Assessment of urinary system function by pattern matching
-- Methods for monitoring blood flow in the prostate gland
-- Digitally-supported physiological sensors
-- Light intensity controls for NIRS
-- Protection against unintended light exposure

For additional details on our patent portfolio, please e-mail info@urodynamix.com.